相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。3CL Protease Inhibitors with an Electrophilic Arylketone Moiety as Anti-SARS-CoV-2 Agents
Sho Konno et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2
Kaifu Gao et al.
CHEMICAL REVIEWS (2022)
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities
Rolando Cannalire et al.
JOURNAL OF MEDICINAL CHEMISTRY (2022)
Targeting the Main Protease of SARS-CoV-2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors
Julian Breidenbach et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
A drug repurposing screen identifies hepatitis C antivirals as inhibitors of the SARS-CoV2 main protease
Jeremy D. Baker et al.
PLOS ONE (2021)
SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model
Jingxin Qiao et al.
SCIENCE (2021)
Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19
Kas Steuten et al.
ACS INFECTIOUS DISEASES (2021)
Evaluation of the Antiviral Activity of Sitagliptin-Glatiramer Acetate Nano-Conjugates against SARS-CoV-2 Virus
Nabil A. Alhakamy et al.
PHARMACEUTICALS (2021)
Repurposing of Some Natural Product Isolates as SARS-COV-2 Main Protease Inhibitors via In Vitro Cell Free and Cell-Based Antiviral Assessments and Molecular Modeling Approaches
Hossam M. Abdallah et al.
PHARMACEUTICALS (2021)
Protease targeted COVID-19 drug discovery: What we have learned from the past SARS-CoV inhibitors?
Sk Abdul Amin et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries
Rui Wang et al.
GENOMICS (2021)
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
Sho Iketani et al.
NATURE COMMUNICATIONS (2021)
A Study of 3CLpros as Promising Targets against SARS-CoV and SARS-CoV-2
Seri Jo et al.
MICROORGANISMS (2021)
Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
Keivan Zandi et al.
MICROORGANISMS (2021)
Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs
Bruno Rizzuti et al.
BIOMEDICINES (2021)
Discovery of chebulagic acid and punicalagin as novel allosteric inhibitors of SARS-CoV-2 3CLpro
Ruikun Du et al.
ANTIVIRAL RESEARCH (2021)
Synthetic and computational efforts towards the development of peptidomimetics and small-molecule SARS-CoV 3CLpro inhibitors
Abhik Paul et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals
Le-Yun Sun et al.
BIOORGANIC CHEMISTRY (2021)
Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection
Chamandi S. Dampalla et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Protease inhibitor GC376 for COVID-19: Lessons learned from feline infectious peritonitis
Khan Sharun et al.
ANNALS OF MEDICINE AND SURGERY (2021)
Evaluation of an octahydroisochromene scaffold used as a novel SARS 3CL protease inhibitor
Shin-ichiro Yoshizawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
α-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment
Linlin Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Roujian Lu et al.
LANCET (2020)
A new coronavirus associated with human respiratory disease in China
Fan Wu et al.
NATURE (2020)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Alexandra C. Walls et al.
CELL (2020)
Drug Development and Medicinal Chemistry Efforts toward SARS-Coronavirus and Covid-19 Therapeutics
Arun K. Ghosh et al.
CHEMMEDCHEM (2020)
Cell entry mechanisms of SARS-CoV-2
Jian Shang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
Wenhao Dai et al.
SCIENCE (2020)
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
Linlin Zhang et al.
SCIENCE (2020)
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
Xiuyuan Ou et al.
NATURE COMMUNICATIONS (2020)
Comprehensive Insights into the Catalytic Mechanism of Middle East Respiratory Syndrome 3C-Like Protease and Severe Acute Respiratory Syndrome 3C-Like Protease
Hao Wang et al.
ACS CATALYSIS (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients
Hai-xia Su et al.
ACTA PHARMACOLOGICA SINICA (2020)
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patients
Tianxiao Liu et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
Chunlong Ma et al.
CELL RESEARCH (2020)
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening
Olga Abian et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Repositioning of 8565 Existing Drugs for COVID-19
Kaifu Gao et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2020)
Evaluation of SARS-CoV-2 3C-like protease inhibitors using self-assembled monolayer desorption ionization mass spectrometry
Zachary A. Gurard-Levin et al.
ANTIVIRAL RESEARCH (2020)
The SARS-CoV-2 main protease as drug target
Sven Ullrich et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2020)
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin et al.
NATURE NANOTECHNOLOGY (2020)
3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice
Athri D. Rathnayake et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Discovery of Ketone-Based Covalent Inhibitors of Coronavirus 3CL Proteases for the Potential Therapeutic Treatment of COVID-19
Robert L. Hoffman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Biochemical screening for SARS-CoV-2 main protease inhibitors
Camila Coelho et al.
PLOS ONE (2020)
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
Lifeng Fu et al.
NATURE COMMUNICATIONS (2020)
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication (vol 11, 4282, 2020)
Wayne Vuong et al.
NATURE COMMUNICATIONS (2020)
Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
Praveen Kumar Tripathi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site
Jaeyong Lee et al.
NATURE COMMUNICATIONS (2020)
Ebselen, a new candidate therapeutic against SARS-CoV-2
C. V. Haritha et al.
INTERNATIONAL JOURNAL OF SURGERY (2020)
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-Throughput Screening
Wei Zhu et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
Chunlong Ma et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Structure and inhibition of the SARS-CoV-2 main protease reveal strategy for developing dual inhibitors against Mpro and cathepsin L
Michael Dominic Sacco et al.
SCIENCE ADVANCES (2020)
Unveiling the molecular mechanism of SARS-CoV-2 main protease inhibition from 137 crystal structures using algebraic topology and deep learning
Duc Duy Nguyen et al.
CHEMICAL SCIENCE (2020)
Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds
Pei Liu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Catalytic Cleavage of Disulfide Bonds in Small Molecules and Linkers of Antibody-Drug Conjugates
Donglu Zhang et al.
DRUG METABOLISM AND DISPOSITION (2019)
Evans Blue Inhibits HBV Replication Through a Dual Antiviral Mechanism by Targeting Virus Binding and Capsid Assembly
Yu Xiao et al.
FRONTIERS IN MICROBIOLOGY (2019)
Aldehyde toxicity and metabolism: the role of aldehyde dehydrogenases in detoxification, drug resistance and carcinogenesis
Amaj Ahmed Laskar et al.
DRUG METABOLISM REVIEWS (2019)
Efficacy of a 3C-like protease inhibitor in treating various forms of acquired feline infectious peritonitis
Niels C. Pedersen et al.
JOURNAL OF FELINE MEDICINE AND SURGERY (2018)
Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agents
Konstantina Karypidou et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions
Paul A. Jackson et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Discovery of unsymmetrical aromatic disulfides as novel inhibitors of SARS-CoV main protease: Chemical synthesis, biological evaluation, molecular docking and 3D-QSAR study
Li Wang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Molecular Evolution of Human Coronavirus Genomes
Diego Forni et al.
TRENDS IN MICROBIOLOGY (2017)
Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors
Vathan Kumar et al.
ANTIVIRAL RESEARCH (2017)
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy
Thanigaimalai Pillaiyar et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Reversal of the Progression of Fatal Coronavirus Infection in Cats by a Broad-Spectrum Coronavirus Protease Inhibitor
Yunjeong Kim et al.
PLOS PATHOGENS (2016)
Fused-ring structure of decahydroisoquinolin as a novel scaffold for SARS 3CL protease inhibitors
Yasuhiro Shimamoto et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Identification of novel drug scaffolds for inhibition of SARS-CoV 3-Chymotrypsin-like protease using virtual and high-throughput screenings
Hyun Lee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Synthesis, modification and docking studies of 5-sulfonyl isatin derivatives as SARS-CoV 3C-like protease inhibitors
Wei Liu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Chemical con artists foil drug discovery
Jonathan Baell et al.
NATURE (2014)
Design and synthesis of new tripeptide-type SARS-CoV 3CL protease inhibitors containing an electrophilic arylketone moiety
Sho Konno et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding
Mark Turlington et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Design, synthesis, and biological evaluation of novel dipeptide-type SARS-CoV 3CL protease inhibitors: Structure-activity relationship study
Pillaiyar Thanigaimalai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Development of potent dipeptide-type SARS-CoV 3CL protease inhibitors with novel P3 scaffolds: Design, synthesis, biological evaluation, and docking studies
Pillaiyar Thanigaimalai et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases
Chi-Pang Chuck et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Anti-SARS coronavirus agents: a patent review (2008-present)
Vathan Kumar et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2013)
Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease
Jon Jacobs et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
3C Protease of Enterovirus 68: Structure-Based Design of Michael Acceptor Inhibitors and Their Broad-Spectrum Antiviral Effects against Picornaviruses
Jinzhi Tan et al.
JOURNAL OF VIROLOGY (2013)
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases
Ji-Young Park et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2012)
Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
Yunjeong Kim et al.
JOURNAL OF VIROLOGY (2012)
Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
Lili Zhu et al.
ANTIVIRAL RESEARCH (2011)
Virtual screening identification of novel severe acute respiratory syndrome 3C-like protease inhibitors and in vitro confirmation
Thi Thanh Hanh Nguyen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)
Structure-Based Design, Synthesis, and Evaluation of Peptide-Mimetic SARS 3CL Protease Inhibitors
Kenichi Akaji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Biflavonoids from Torreya nucifera displaying SARS-CoV 3CLpro inhibition
Young Bae Ryu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Synthesis and evaluation of pyrazolone compounds as SARS-coronavirus 3C-like protease inhibitors
R. Ramajayam et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
SARS-CoV 3CLpro inhibitory effects of quinone-methide triterpenes from Tripterygium regelii
Young Bae Ryu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Synthesis and Evaluation of Benzoquinolinone Derivatives as SARS-CoV 3CL Protease Inhibitors
Tae-Young Ahn et al.
BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2010)
Molecular Mechanism of Inhibition of the Human Protein Complex Hsp90-Cdc37, a Kinome Chaperone-Cochaperone, by Triterpene Celastrol
Sridhar Sreeramulu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CLpro inhibitors
Thomas Regnier et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Individual and common inhibitors of coronavirus and picornavirus main proteases
Chih-Jung Kuo et al.
FEBS LETTERS (2009)
Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds
Cheng-Chung Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV M-pro
Chunying Niu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Structure-based virtual screening against SARS-3CLpro to identify novel non-peptidic hits
Prasenjit Mukherjee et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease
Yi-Ming Shao et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors
Arun K. Ghosh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase
Jianmin Zhang et al.
BIOORGANIC CHEMISTRY (2008)
Development of broad-spectrum halomethyl ketone inhibitors against coronavirus main protease 3CLpro
Usman Bacha et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2008)
A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters
Koen H. G. Verschueren et al.
CHEMISTRY & BIOLOGY (2008)
Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors
Cheng-Chung Lee et al.
FEBS LETTERS (2007)
Structure-based design,synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors
Arun K. Ghosh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Structure-based design and synthesis of highly potent SARS-CoV 3CL protease inhibitors
Yi-Ming Shao et al.
CHEMBIOCHEM (2007)
Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus
Chih-Chun Wen et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus
D. H. Goetz et al.
BIOCHEMISTRY (2007)
Pharmacophores and biological activities of severe acute respiratory syndrome viral protease inhibitors
Hui-Min Wang et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2007)
Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters
Jianmin Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Production of authentic SARS-CoV Mpro with enhanced activity:: Application as a novel tag-cleavage endopeptidase for protein overproduction
Xiaoyu Xue et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Binding interaction of quereetin-3-β-galactoside and its synthetic derivatives with SARS-CoV 3CLpro:: Structure-activity relationship studies reveal salient pharmacophore features
Lili Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Discovering severe acute respiratory syndrome coronavirus 3CL protease inhibitors: Virtual screening, surface plasmon resonance, and fluorescence resonance energy transfer assays
Lili Chen et al.
JOURNAL OF BIOMOLECULAR SCREENING (2006)
Synthesis of glutamic acid and glutamine peptides possessing a trifluoromethyl ketone group as SARS-CoV 3CL protease inhibitors
Magne O. Sydnes et al.
TETRAHEDRON (2006)
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease
I-Lin Lu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Synthesis, crystal structure, structure-activity relationships, and antiviral activity of a potent SARS coronavirus 3CL protease inhibitor
Syaulan Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Development of a red-shifted fluorescence-based assay for SARS-coronavirus 3CL protease:: identification of a novel class of anti-SARS agents from the tropical marine sponge Axinella corrugata
Pamela Hamill et al.
BIOLOGICAL CHEMISTRY (2006)
Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors
Lu Zhou et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies
Keng-Chang Tsai et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Stable benzotriazole esters as mechanism-based inactivators of the severe acute respiratory syndrome 3CL protease
CY Wu et al.
CHEMISTRY & BIOLOGY (2006)
Design and synthesis of dipeptidyl glutaminyl fluoromethyl ketones as potent severe acute respiratory syndrome coronovirus (SARS-CoV) inhibitors
HZ Zhang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Characterization and inhibition of SARS-coronavirus main protease
Po-Huang Liang
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2006)
Screening of electrophilic compounds yields an aziridin, as new active-site directed SARS-CoV main protease inhibitor
E Martina et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide
TW Lee et al.
JOURNAL OF MOLECULAR BIOLOGY (2005)
Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors
AK Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
A new lead for nonpeptidic active-site-directed inhibitors of the severe acute respiratory syndrome coronavirus main protease discovered by a combination of screening and docking methods
U Kaeppler et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Design of wide-spectrum inhibitors targeting coronavirus main proteases
HT Yang et al.
PLOS BIOLOGY (2005)
Inhibition of the severe acute respiratory syndrome 3CL protease by peptidomimetic α,β-unsaturated esters
JJ Shie et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease
YC Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Discovery of potent anilide inhibitors against the severe acute respiratory syndrome 3CL protease
JJ Shie et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors
LR Chen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2005)
Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro
LL Chen et al.
JOURNAL OF VIROLOGY (2005)
Severe acute respiratory syndrome coronavirus 3C-like proteinase n terminus is indispensable for proteolytic activity but not for enzyme dimerization - Biochemical and thermodynamic investigation in conjunction with molecular dynamics simulations
S Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3 '- digallate (TF3)
CN Chen et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2005)
Evaluation of metal-conjugated compounds as inhibitors of 3CL protease of SARS-CoV
JTA Hsu et al.
FEBS LETTERS (2004)
Identification of novel small-molecule inhibitors of severe acute respiratory syndrome-associated coronavirus by chemical genetics
RY Kao et al.
CHEMISTRY & BIOLOGY (2004)
Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro
RP Jain et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Small molecules targeting severe acute respiratory syndrome human coronavirus
CY Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Characterization of SARS-CoV main protease and identification of biologically active small molecule inhibitors using a continuous fluorescence-based assay
RY Kao et al.
FEBS LETTERS (2004)
High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase
JE Blanchard et al.
CHEMISTRY & BIOLOGY (2004)
Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro
U Bacha et al.
BIOCHEMISTRY (2004)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
The genome sequence of the SARS-associated coronavirus
MA Marra et al.
SCIENCE (2003)
Irreversible inhibitors of serine, cysteine, and threonine proteases
JC Powers et al.
CHEMICAL REVIEWS (2002)
Role of reactive aldehyde in cardiovascular diseases
K Uchida
FREE RADICAL BIOLOGY AND MEDICINE (2000)
分享论文
